CRSP vs WAB · rev $11.6M vs P/E 38, rev $3.18B
Crispr Therapeutics AG (CRSP) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
CRSP currently screens at market cap $5.42B. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the CRSP and WAB stock pages for the full models.
Not investment advice.